If you live with Crohn’s disease or ulcerative colitis, you’ve likely heard about the gut microbiome and its possible role in inflammation. Understanding what happens when this microbial community becomes imbalanced can help make sense of why certain foods or lifestyle factors seem to worsen or ease symptoms. The connection between your gut bacteria and inflammatory bowel disease (IBD) is now one of the most researched areas in gastroenterology.
What is the gut microbiome?
The gut microbiome refers to the trillions of bacteria, viruses, fungi, and other microorganisms that live in your digestive tract, particularly in the colon. These microbes are not passive residents. They break down fibres and other nutrients, produce vitamins and short-chain fatty acids, communicate with immune cells, and help maintain the integrity of the gut lining. In a healthy gut, this microbial community is diverse, stable, and mostly made up of species that support normal immune function and tissue repair.
What is dysbiosis and why does it matter in IBD?
Dysbiosis describes a state in which the balance of microbes in the gut has shifted away from health-supporting species towards those that may promote inflammation or fail to protect the gut lining. In people with IBD, dysbiosis is a consistent finding. Studies have shown that the microbiomes of those with Crohn’s disease and ulcerative colitis tend to have reduced diversity, lower numbers of beneficial bacteria such as Faecalibacterium prausnitzii, and increases in certain potentially harmful species.
This imbalance matters because the microbiome helps regulate immune responses in the gut. When beneficial bacteria decline, the production of anti-inflammatory molecules like butyrate can drop. At the same time, certain bacteria may release compounds that activate immune cells or damage the mucus layer that protects the intestinal lining. The result is an environment that makes the gut more vulnerable to inflammation and less able to repair itself.
How dysbiosis may contribute to IBD
Dysbiosis does not cause IBD on its own, but it appears to interact with genetic susceptibility, immune function, and environmental triggers to influence disease activity. Several mechanisms help explain this relationship.
Loss of protective bacteria
Certain bacterial species produce short-chain fatty acids, particularly butyrate, when they ferment dietary fibre. Butyrate is used as fuel by the cells lining the colon and has anti-inflammatory effects on local immune cells. In IBD, populations of butyrate-producing bacteria are often reduced. This loss may weaken the gut barrier and reduce the ability of the gut to regulate inflammation.
Increased gut permeability
A healthy gut lining acts as a selective barrier, allowing nutrients through while keeping bacteria and toxins out of the bloodstream. Dysbiosis can weaken the tight junctions between gut cells, a condition sometimes referred to as increased gut permeability or leaky gut. When this happens, bacterial fragments and other molecules can cross into tissues beneath the gut lining, triggering immune responses that sustain inflammation.
Immune system activation
The immune system in the gut is designed to tolerate harmless bacteria and food while responding to threats. Dysbiosis can confuse this system. When beneficial bacteria decline and potentially inflammatory species increase, immune cells may become overactive or lose their ability to distinguish friend from foe. In people genetically predisposed to IBD, this immune dysregulation can lead to chronic, inappropriate inflammation.
Reduced microbial diversity
A diverse microbiome is generally more resilient and better able to recover from disruptions like infection, antibiotics, or dietary changes. People with IBD often have lower microbial diversity, which may make the gut more vulnerable to flares and less responsive to dietary or medical interventions. Restoring diversity is a key target of microbiome-focused therapies.
What influences the microbiome in IBD?
Several factors can shape the composition of the gut microbiome, and understanding these can inform practical decisions.
Diet
Diet is one of the most modifiable factors affecting the microbiome. Fibre from fruits, vegetables, whole grains, and legumes feeds beneficial bacteria and promotes short-chain fatty acid production. Conversely, diets high in processed foods, added sugars, and emulsifiers may promote dysbiosis. In IBD, tolerance to fibre varies, especially during flares, so changes should be gradual and personalised.
Medications
Antibiotics can significantly reduce microbial diversity, and while they are sometimes necessary, their use should be carefully considered. Some IBD medications, such as aminosalicylates and biologics, may also influence the microbiome, though the effects vary. Probiotics and prebiotics are often discussed, but evidence for their benefit in IBD is mixed and strain-specific.
Stress and sleep
Chronic stress and poor sleep can alter gut motility, immune function, and the composition of the microbiome. These effects are bidirectional, meaning that an unhealthy microbiome may also worsen stress responses. Managing stress through structured approaches may support microbial health alongside other benefits.
Smoking and alcohol
Smoking is associated with worse outcomes in Crohn’s disease and has been shown to alter the gut microbiome in ways that may increase inflammation. Alcohol can also disrupt microbial balance and irritate the gut lining. Both are best minimised or avoided in IBD.
Can you improve your microbiome with IBD?
Improving the microbiome in IBD is possible, but it requires patience and realistic expectations. The goal is not to eliminate all symptoms or replace medical treatment, but to support a more stable and diverse microbial community over time.
Gradually increasing fibre intake, when tolerated, is one of the most evidence-supported strategies. Soluble fibres such as oats, psyllium, and cooked vegetables are often better tolerated than insoluble fibres during active disease. Fermented foods like kefir, sauerkraut, and natural yoghurt may also support microbial diversity, though individual responses vary.
Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA), have anti-inflammatory properties and may support a healthier microbial environment. While omega-3 supplementation does not cure IBD, it may help modulate inflammatory signalling and support gut barrier function when used alongside standard treatment.
Consistency matters more than perfection. Small, sustained changes to diet and lifestyle are more likely to benefit the microbiome than short-term interventions. It is also important to remember that symptoms do not always reflect inflammation, and that microbiome changes take time to translate into clinical benefits.
Conclusion
The gut microbiome plays a significant role in the development and progression of IBD, but it is not the sole cause. Dysbiosis, characterised by reduced diversity and altered bacterial populations, interacts with genetics and immune function to influence inflammatory activity. While the microbiome cannot be entirely controlled, diet, lifestyle, and medical management can support a more stable microbial environment. These efforts work best as part of a broader strategy for long-term disease management, not as replacements for medical care.
References
1. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9(10):599-608. doi:10.1038/nrgastro.2012.152
2. Ananthakrishnan AN, Bernstein CN, Iliopoulos D, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39-49. doi:10.1038/nrgastro.2017.136
3. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105(43):16731-16736. doi:10.1073/pnas.0804812105
4. Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017;152(2):398-414. doi:10.1053/j.gastro.2016.10.019
5. Khalili H, Håkansson N, Chan SS, et al. Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn’s disease: results from two large prospective cohort studies. Gut. 2020;69(9):1637-1644. doi:10.1136/gutjnl-2019-319505
6. Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105-1115. doi:10.1042/BST20160474
7. Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med. 2019;216(1):20-40. doi:10.1084/jem.20180448
8. Fritsch J, Garces L, Quintero MA, et al. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2021;19(6):1189-1199. doi:10.1016/j.cgh.2020.05.026
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.